In the present study, we aimed to determine whether DJ-1 is a useful serum biomarker for the diagnosis of urothelial carcinoma (UC) and whether the immunohistochemical expression of DJ-1 protein in patients treated with radical cystectomy can be used to assess the progression of BC. The gene discussed is PARK7; the disease is urothelial carcinoma.